Follow the 派林生物 stock price and the full insider trade history of the company, a publicly traded company based in China. Shares trade on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 派林生物 has recorded 23 insider filings. Market capitalisation: €10.1bn. The latest transaction was reported on 20 May 2026 (Purchase). Among the most active insiders: 黄灵谋. All data is accessible without an account.
23
Insider Decl.
n/a
Thresholds
€545,445
17 ops.
Buy Volume
€16m
6 ops.
Sell Volume
22Σ signal
Buys €545,445€16m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 15,781 of 28,717 companies
49.3
score / 100
Value
38
Quality
61
FCF yld-5.4%
Earn yld4.2%
EV/EBITDA16.5x
ROE4.4%
Gross mgn42%
Net mgn16%
Debt/EBITDA1.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
